Výsledky vyhledávání - "Svetlana V. Teplykh"

Akademický článek

The effect of etiopathogenetic therapy of COVID-19 on the severity of the disease: results of a multicenter double-blind placebo-controlled randomized trial

Autor: Vladimir V. Nikiforov, Vladimir A. Petrov, Anatoly A. Stremoukhov, Marina G. Avdeeva, Yury G. Shvarts, Irina E. Kravchenko, Irina V. Nikolaeva, Svetlana E. Ushakova, Oksana N. Belousova, Natal'ia A. Eremina, Svetlana V. Teplykh, Ekaterina V. Mel'nikova, Natal'ia E. Kostinа

Publikováno v: Терапевтический архив, Vol 95, Iss 11, Pp 958-964 (2023)

Aim. The search for etiopathogenetic agents to prevent the development of severe and extremely severe COVID-19 remains relevant. A placebo-controlled randomized clinical trial was conducted to evaluate the efficacy and safety of the antibody-based bi

Externí odkaz: https://doaj.org/article/5536203adb4e4dc7874f20f741c51566

Zobrazit plný text záznamu

Akademický článek

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial

Autor: Aleksandr V. Kudriavtsev, Anna V. Vakhrusheva, Nickolay A. Kryuchkov, Maria E. Frolova, Konstantin A. Blagodatskikh, Taras V. Ivanishin, Milana Djonovic, Ekaterina A. Romanovskaya-Romanko, Anton N. Kovalenko, Dmitry A. Lioznov, Tatiana G. Zubkova, Svetlana V. Teplykh, Rodion A. Oseshnyuk, Marina A. Stukova, Artur A. Isaev, Igor V. Krasilnikov

Publikováno v: Vaccines, Vol 11, Iss 2, p 326 (2023)

COVID-19, being a life-threatening infection that evolves rapidly, remains a major public health concern calling for the development of vaccines with broad protection against different pathogenic strains and high immunogenicity. Aside from this, othe

Externí odkaz: https://doaj.org/article/6fbf32a2521448a5b2cad584c69fbc01

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání